Health Condition 1: null- Non Small Cell Lung Cancer
Conditions
Interventions
None listed
Sponsors
Roche Products India Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria Patients must meet the following criteria for study entry: · Adult male or female patients of age >= 18years. · Diagnosed case of NSCLC with availability of representative tumor specimen for genetic analysis, from the biopsy sample. · Written informed consent
Exclusion criteria
Exclusion criteria: Patients who meet the following criteria will be excluded from study: · Patients, who in the opinion of the investigator, are unable to comply with study requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of EGFR mutations in NSCLC patients in Indian population.Timepoint: Interim analysis will be done at completion of 50% of planned subjects are enrolled Expected at around March 2014 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Prevalence of different types of EGFR mutations in NSCLC patients in Indian population â?¢ Correlation of EGFR mutation status with demography â?¢ Correlation of EGFR mutation status with linico-pathological characteristics â?¢ In treatment experienced patients, analysis of correlation between EGFR mutation and treatment outcomeTimepoint: Interim analysis will be done at completion of 50% of planned subjects are enrolled Expected at around Mar 2014 Final Analysis in Oct 2014 | — |
Countries
India
Contacts
Public ContactDr Aditi Parekh
Roche Products (India) Pvt. Ltd.
Outcome results
None listed